α-radioligand therapy

Open Access
First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen–Targeted ²¹²Pb Radioligand, in Patients with Metastatic Castration-Resistant Prostate Cancer
Kjetil Berner, Eivor Hernes, Monika Kvassheim, Mona-Elisabeth Revheim, Julie Bastiansen, Silje Selboe, Charlotte L. Bakken, Simen R. Grønningsæter, Øyvind S. Bruland, Roy H. Larsen, Lily Bouzelmat, Vicki L. Jardine and Caroline Stokke

Journal of Nuclear Medicine May 1, 2025, 66 (5) 732-738; DOI: https://doi.org/10.2967/jnumed.124.269299

Main menu